Overexpressing IRS1 in Endothelial Cells Enhances Angioblast Differentiation and Wound Healing in Diabetes and Insulin Resistance
Sayaka Katagiri(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Amy J. Wagers(Harvard University), Luca Lancerotto(Brigham and Women's Hospital), Akira Mima(Osaka University of Pharmaceutical Sciences), Yasutaka Maeda(Kyushu University), Tata Nageswara Rao(University of St.Gallen), Hisashi Yokomizo(Joslin Diabetes Center), Dennis P. Orgill(Brigham and Women's Hospital), Kyoungmin Park(Joslin Diabetes Center), Mogher Khamaisi, Qian Li(Joslin Diabetes Center)
Cited by 38
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k